Treatment for Osteoporosis among Women in Japan: Associations with Patient Characteristics and Patient-Reported Outcomes in the 2008–2011 Japan National Health and Wellness Surveys

Table 5

Regression-adjusted mean outcomes according to type of osteoporosis treatment.

	Raloxifene		Bisphosphonates		Active vitamin D3 alone		Calcitonin alone		value^1
	Adjusted mean	SE	Adjusted mean	SE	Adjusted mean	SE	Adjusted mean	SE
HRQoL
MCS	50.5	1.6	46.8	0.9	45.3	1.5	49.2	1.6	0.027
PCS	42.1	1.6	42.4	0.9	40.8	1.5	42.6	1.7	0.747
SF-6D	0.725	0.022	0.697	0.013	0.677	0.020	0.732	0.022	0.138
Activity impairment (%)	30.7	4.4	33.7	2.8	34.7	4.9	32.6	4.8	0.911
6-month healthcare use
Physician visits	11.9	1.8	16.5	1.4	18.3	2.5	14.6	2.2	0.102
ER visits	0.2	0.2	0.3	0.1	0.3	0.2	0.4	0.4	0.916
Hospitalizations	4.2	3.6	2.0	0.8	1.2	1.1	1.7	1.4	0.700

 ¹Wald chi-square for treatment group; HRQoL: health-related quality of life; MCS: mental component summary; PCS: physical component summary; ER: emergency room.